Role of disintoxication and antioxidant therapy for COVID-19: theory and practice
- 作者: Khavkina D.A.1,2, Ruzhentsova T.A.1, Chukhlyaev P.V.1,2, Garbuzov A.A.1, Shushakova E.K.1
-
隶属关系:
- Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
- A.S. Puchkov Ambulance and Emergency Medical Service, Moscow Healthcare Department
- 期: 卷 10, 编号 2 (2020)
- 页面: 62-69
- 栏目: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/287521
- DOI: https://doi.org/10.18565/epidem.2020.10.3.62-9
- ID: 287521
如何引用文章
详细
全文:
![受限制的访问](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
作者简介
Daria Khavkina
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being; A.S. Puchkov Ambulance and Emergency Medical Service, Moscow Healthcare Department
Email: havkina@gmail.com
Tatiana Ruzhentsova
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: ruzhencova@gmail.com
Pavel Chukhlyaev
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being; A.S. Puchkov Ambulance and Emergency Medical Service, Moscow Healthcare Department
Email: pafachka@gmail
Aleksandr Garbuzov
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: os.vertebra@mail.ru
Ekaterina Shushakova
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: ketlu@bk.ru
参考
- WHO. Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020. https://www.who.int/dg/ speeches/ detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020
- Tang X., Wu C., Li X., Song Yu-He, Yao X., Wu X. et al. On the origin and continuing evolution of SARS-CoV-2. National Science Review 2020. doi: 10.1093/nsr/nwaa036
- Centers for Disease Control and Prevention. 2019 Novel coronavirus, Wuhan, China. Information for Healthcare Professionals. https://www.cdc.gov/ coronavirus/2019-nCoV/ hcp/index.html
- WHO. Novel Coronavirus (2019-nCoV) technical guidance. https://www.who.int/emergencies/diseases/novel-corona-virus-2019/ technical-guidance
- WHO Director-General’s opening remarks at the mission briefing on COVID-19 - 26 February 2020. https://www. who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the -mission-briefing- on-covid-19-26-fe
- Russell C.D., Millar J.E., Baillie J.K. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 2020; 395: 473-5. https://xn--aciltp-t9a.com/ wp-content/uploads/2020/04/20-03-06-clinical-evidence-does-not-support-corticosteroid-treatment.pdf
- European Centre for Disease Prevention and Control. Novel coronavirus in China. https://www.ecdc.europa.eu/en/novel-coronavirus-china
- WHO Disease outbreak news: Novel Coronavirus - Republic of Korea (ex-China). January 21, 2020. https://www.who. int/csr/don/21-january-2020-novel-coronavirus-republic-of-korea-ex-china/en/
- Centers for Disease Control and Prevention. First travel-related case of 2019 novel coronavirus detected in United States, January 21, 2020. https://www.cdc.gov/media/releases/2020/ p0121-novel-coronavirus-travel-case.html
- Centers for Disease Control and Prevention. Second travel-related case of 2019 novel coronavirus detected in United States, January 24, 2020. https: //www.cdc.gov/media/releases/2020/ p0124-second-travel-coronavirus. html
- Day M. Covid-19: Ibuprofen Should not be Used for Managing Symptoms, Say Doctors and Scientists. BMJ 2020; 368: m1086.
- Yao X., Ye F., Zhang M., Cui Ch., Huang B., Niu Peihua et al. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin. Infect. Dis. 2020. https://pubmed.ncbi.nlm.nih. gov/32150618/
- European Centre for Disease Prevention and Control. Geographical distribution of 2019-nCov cases. https://www. ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases
- Centers for Disease Control and Prevention. 2019 Novel Coronavirus (2019-nCoV) in the US. https://www.cdc.gov/ coronavirus/2019-ncov/cases-in-us.html
- Gao J., Tian Z., Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 2020; 14: 72. doi: 10.5582/bst.2020.01047
- Colson P., Rolain J.M., Lagier J.C., Brouqui P, Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int. J. Antimicrob. Agents 2020; 55(4): 105932. doi: 10.1016/j.ijantimicag.2020. 105932
- Gautret Ph., Gautret P., Lagier J.C., Parola P. et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int. J. Antimicrob. Agents 2020: 105949. DOI:10.1016/j. ijantimicag.2020.105949
- Groneberg D.A., Poutanen S.M., Low D.E., Lode H., Welte T., Zabel P. Treatment and vaccines for severe acute respiratory syndrome. Lancet Infect. Dis. 2005; (5): 147-55.
- Chan J.F., Yao Y., Yeung M.L., Deng W., Bao L., Jia L. et al. Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset. J. Infect. Dis. 2015; 212: 1904. doi: 10.1093/infdis/jiv392
- WHO. Novel coronavirus. Situation report-2. January 22, 2020. https://www.who.int/docs/default-source/coronaviruse/ situation-reports/ 20200122-sitrep-2-2019-ncov.pdf
- Cao B., Wang Y., Wen D., Liu W., Wang J., Fan G. et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N. Engl. J. Med. 2020; 382(19): 1787-99. doi: 10.1056/NEJMoa2001282
- Wang Y., Liu Y., Liu L., Liu L., Wang X., Luo N. et al. Clinical outcome of 55 asymptomatic cases at the time of hospital admission infected with SARS-Coronavirus-2 in Shenzhen, China. J. Infect. Dis. 2020. DOI:10.1093/ infdis/jiaa119
- Pan F., Ye T., Sun P., Gui S., Liang B., Li L. et al. Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia. Radiology 2020. https://doi.org/10.1148/radiol. 2020200370
- Shi H., Han X., Jiang N., Cao Y., Alwalid O., Gu J. et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect. Dis. 2020. https://doi.org/10.1016/S1473-3099(20) 30086-4
- Chang D., Lin M., Wei L., Xie L., Zhu G., Dela Cruz C.S. Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China. JAMA 2020. https://jamanetwork.com/journals/jama/ fullarticle/2761043
- Xu X.W., Wu X.X., Jiang X.G., Xu K.J., Ying L.J., Maet C.L. al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 2020; 368: m606. DOI:10.1136/ bmj.m606
- Wu J., Liu J., Zhao X. Liu Ch. Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study. Clin. Infect. Dis. 2020. doi: 10.1093/cid/ciaa 19 9
- Wu C., Chen X., Cai Y., Xia J., Zhou X., Xu S. et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern. Med. 2020. https://jamanetwork.com/journals/jamainternalmedicine/ fullarticle/29.2763184
- Zhao W., Zhong Z., Xie X., et al. Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study. AJR Am. J. Roentgenol. 2020. doi.org/10.2214/AJR.20. 22976
- Ai T., Yang Z., Hou H., Zhan C., Chen C., Lv Wet al. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology 2020. doi: 10.1148/radiol. 2020200642
- Bai H.X., Hsieh B., Xiong Z., Halsey K., Bai X., Hsieh B. et al. Performance of Radiologists in Differentiating COVID-19 from Viral Pneumonia on Chest CT. Radiology 2020. doi: 10.1148/radiol.2020200823
- Xie X., Zhong Z., Zhao W., Zheng Ch., Wang F., Liu J. et al. Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing. Radiology 2020; 200343. doi: 10.1148/radiol.2020200343
- Centers for Disease Control and Prevention. Updated Guidance on Evaluating and Testing Persons for COVID 19. HAN429. https://emergency.cdc.gov/ han/2020/han004029. asp?deliveryName=USCDC_511-DM22015
- Centers for Disease Control and Prevention. Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons Under Investigation (PUIs) for Coronavirus Disease 2019 (COVID-19). https://www.cdc. gov/ coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html
- Patel A., Jernigan D.B. 2019-nCoV CDC Response Team. Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019 - February 4, 2020. MMWR Morb. Mortal. Wkly Rep. 2020; 69: 140-6.
- WHO. Coronavirus disease (COVID-19) technical guidance: Surveillance and case definitions. https://www.who.int/ emergencies/diseases/novel-coronavirus-2019/technical-guidance/surveillance-and-case-definitions
- WHO. Novel Coronavirus (2019-nCoV) technical guidance: Patient management. https://www.who.int/emergencies/ diseases/novel-coronavirus-2019/technical-guidance/patient-management
- WHO. Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts. https://www.who.int/ publications- detail/home-care -for-patients-with- suspected-novel-coronavirus-(ncov)-infection-presenting-with-mild-symptoms-and-management-of-contacts
- Профилактика, диагностика и лечение новой коронави-русной инфекции (Covid-19). Временные методические рекомендации Минздрава России. Версия 6 (28.04.2020). https://static1.rosminzdrav.ru/system/attachments/ attaches/000/050/122/original/28042020_MR_COVID-19_ v6.pdf.
- Регистр лекарственных средств России. https://www. rlsnet.ru
补充文件
![](/img/style/loading.gif)